(Q52985831)

10 May 2018

title

(68)Ga-PSMA PET/CT imaging in primary hepatocellular carcinoma. (English)

1 reference

10 May 2018

author name string

Arun Sasikumar

1

1 reference

10 May 2018

Ajith Joy

2

1 reference

10 May 2018

Raviteja Nanabala

3

1 reference

10 May 2018

M R A Pillai

4

1 reference

10 May 2018

Boben Thomas

5

1 reference

10 May 2018

K R Vikraman

6

1 reference

10 May 2018

publication date

8 January 2016

1 reference

10 May 2018

European Journal of Nuclear Medicine and Molecular Imaging

published in

1 reference

10 May 2018

volume

43

1 reference

10 May 2018

issue

4

1 reference

10 May 2018

page(s)

795-796

1 reference

10 May 2018

https://scigraph.springernature.com/pub.10.1007/s00259-015-3297-x

exact match

0 references

cites work

The diagnostic value of PET/CT imaging with the (68)Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3297-X

(68)Ga-PSMA PET/CT imaging of metastatic clear cell renal cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3297-X

⁶⁸Ga-PSMA imaging of metastatic breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3297-X

Prostate specific membrane antigen (PSMA) expression in primary gliomas and breast cancer brain metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3297-X

Engineering a prostate-specific membrane antigen-activated tumor endothelial cell prodrug for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3297-X

10.1007/S00259-015-3297-X

21 January 2018

Identifiers

DOI

1 reference

10 May 2018

PubMed ID

26743897

1 reference

10 May 2018